• Company
• Commercialization of 3rd new P-CAB drug near
• by Kim, Jin-Gu Jun 8, 2023 05:33am

• Company
• Yuhan presents 4 studies at ASCO...builds reliability
• by Jung, Sae-Im Jun 8, 2023 05:33am

• Company
• Novartis counterattacks against Celltrion / a patent lawsuit
• by Kim, Jin-Gu Jun 7, 2023 09:47pm

• Company
• Kwangdong wins patent lawsuit against Ibrance in reverse
• by Kim, Jin-Gu Jun 7, 2023 05:38am

• Company
• Sales of anti-cancer drug 'Taxol' increases by 53%
• by Kim, Jin-Gu Jun 7, 2023 05:38am

• Company
• Pfizer's ADC Mylotarg can be prescribed by Big 5
• by Eo, Yun-Ho Jun 7, 2023 05:38am

• Company
• 'Saxenda' continues to dominate weight-loss market
• by Kim, Jin-Gu Jun 7, 2023 05:38am

• Policy
• Voluntary price reduction of Diacomit/Olpadine up to↓40%
• by Lee, Hye-Kyung Jun 5, 2023 05:37am

• Policy
• Evrysdi, a tx for Roche's spinal muscular dystrophy, passed
• by Lee, Hye-Kyung Jun 5, 2023 05:37am

• Policy
• Non-face-to-face demonstration will be alternative relief ?
• by Lee, Jeong-Hwan Jun 5, 2023 05:37am